Moonshots and Mop Buckets: When AI Investment Math Actually Works in Private Equity 

Executive Summary: AI in Private Equity – Where the Economics Work 

• AI can create measurable value in private equity when aligned with hold periods and portfolio strategy. 

• Incremental automation delivers 1–3% efficiency gains and becomes more impactful when deployed across multiple portfolio companies. 

• Transformational AI “moonshots” carry high cost, long timelines and elevated execution risk. 

• The economics improve when AI is deployed at the portfolio or sector level rather than treated as an isolated company initiative. 

• Treating AI as a repeatable operating capability, not a one-off experiment, fundamentally changes the return profile. 

Every private equity professional is asking the same deceptively simple question when they look across the portfolio: What are we actually doing about AI, and where does it create real value within a hold period?  Management teams are eager. Advisors are enthusiastic. AI vendors are everywhere. But as a sponsor, your concern is more fundamental: does any of this actually create value within our targeted hold period? 

This is the central tension surrounding AI in private equity today: separating genuine value creation from innovation theater. 

Maybe you’ve sat through too many pitches. You’ve heard consultants promise transformation. You’ve seen the LinkedIn posts and conference slides. And you’re skeptical because the proof points are thin, and the hype is exhausting. The MIT “State of AI in Business 2025” report confirms your instinct: 95% of Generative AI pilots deliver zero return on investment or maybe you’re still bullish. You remember the first time you had a real conversation with AI and the moment when the potential clicked. Since then, you’ve transformed your own operations. You’re using it to source deals, stress-test assumptions, and accelerate diligence. Now you want to bring that same edge to your portfolio companies. 

Still, AI can’t be ignored. Many private equity firms are already using it effectively for sourcing, market research, diligence, and stress-testing assumptions. The question is whether that value creation translates to portfolio companies and under PE economics. 

At a high level, AI investments fall into two buckets: Moonshots and Mop Buckets. 

• Moonshots are transformational bets. Custom AI that fundamentally changes how a business operates. 

• Mop buckets are unglamorous automation. Workflow improvements that don’t make headlines but can incrementally move EBITDA. 

Both can create value. The question is when does the math actually work? 

The Single Company Challenge

The instinct is reasonable: pick a portfolio company, automate their accounts payable, clean up reporting and build some workflows to speed up customer onboarding. The tools already exist: Zapier, n8n and other off-the-shelf Software-as-a-Service (Saas) products. You could hire someone to deploy it. But run the numbers on what it actually takes. 

You’ll need someone dedicated to the work for three to six months to accomplish scoping, building, deploying, debugging and training the team. That’s not a side project; that’s a role. Call it $200,000 – $300,000 loaded cost for a forward-deployed engineer or automation specialist. The portfolio company team needs to be involved too; their time isn’t free. Figure another $50,000 – $100,000 in opportunity cost. You’re looking at $250,000 – $400,000 to get something into production. 

Now ask: What does this need to return? You’ve deployed in year two of your hold, so you have maybe two to three years left. To break even on a $300,000 investment at a 6x multiple, you need roughly $50,000 in annual EBITDA improvement, about 1% on a $5M EBITDA company. That sounds achievable. 

But break-even isn’t the bar. Factor in the risk that it doesn’t work, the management bandwidth consumed and the opportunity cost of capital, and you want something more like 5-10% EBITDA improvement for a clear and meaningful outcome. For a $50M revenue company with $5M EBITDA, that’s a high hurdle. 

Here’s the challenge: Most automation improvements like faster AP processing, cleaner reports and better data extraction get you 1-3% efficiency gains. Not 10%. The economics don’t work for a single company in isolation. But that doesn’t mean they don’t work at all. 

Contact us to discuss how AI strategy can be structured across your portfolio.

The Moonshot Calculus 

So, sponsors look bigger. What if AI transforms the business model? Supply chain optimization. Predictive analytics. AI-driven pricing or recommendations. Deploy predictive analytics that fundamentally alter their service delivery. 

This is the moonshot approach, and the allure is obvious: if it works, you’re not talking about 5-10% EBITDA improvement. You’re talking about real competitive advantage, defensible differentiation and potentially transformational value creation. But the math gets brutal fast. 

Custom AI and Machine Learning solutions take 12-18 months to get to production, not three to six. You’re not spending $300,000, you’re spending $500,000 – $1M+ on data scientists, engineers and infrastructure. The risk of failure isn’t 10%, it’s 50%+. And assuming you own this company for three to five years total, which means you might exit before you even know if it worked. 

Run that expected value: $1M investment, 50% chance of failure, two to three years to see results, one to two years of potential value capture. If success means a $5M enterprise value lift, simple expected value math gives you a $2.5M return on $1M invested. That looks attractive on paper. 

But paper isn’t reality. Factor in the management bandwidth consumed, the opportunity cost of deploying that capital elsewhere, the risk of partial failure (it works but not as well as hoped) and the possibility you either exit before realizing the value or need to extend your hold period. The risk-adjusted return gets much less compelling. 

The Sector Moonshot: Different Math, Still A Big Bet 

Consider a fund backing eight healthcare services companies that believe AI-driven patient intake and care coordination could fundamentally change operational economics across the sector. Or ten industrial distribution businesses where predictive inventory optimization might be a category-level game-changer. 

Now you’re making a different kind of bet. You’re still spending $1-2M+ to develop something meaningful. But you’re potentially deploying it across eight to ten companies, which changes your risk-return profile. If it works for even half of them, you might be creating $10-20M in enterprise value across the portfolio.

The catch is you’re essentially building a vertical Software as a Service (SaaS) product without the benefit of being a SaaS company. You can’t iterate for five years. You don’t have product-market fit feedback from 100 customers. And deploying fund-level initiatives across portfolio companies requires buy-in that isn’t always easy to achieve. 

This can work, but only under very specific conditions: 

• You have genuine sector expertise and deeply understand the operational opportunity 

• You’re willing to partner with technology firms or acqui-hire the capability (don’t build from scratch) 

• You have enough portfolio concentration to deploy across six + similar companies 

• You can move fast. 18 months from concept to production, not three years 

• You have realistic expectations about adoption rates (not all portfolio companies will implement) 

The firms that pull this off treat it like M&A, not R&D: clear thesis, structured diligence, decisive resource allocation and ruthless measurement of outcomes. 

This is a specialized capability, not table stake. If you have the sector concentration and expertise, it’s worth serious consideration. If you don’t, the aggregation model is your path. 

Aggregation: Where the Math Actually Works 

Platform plays in PE aren’t new. Roll up similar businesses, consolidate back-office, standardize operations and achieve economies of scale. That playbook is well established. 

What’s different now is that AI-enabled automation adds a new layer to the platform thesis, one you can deploy before mature SaaS solutions exist for your sector. The vendors are still figuring out AI-native products. Enterprise software is bolting on copilots and assistants. Meanwhile, the building blocks are available: workflow automation tools, APIs and language models that can handle unstructured data. 

This creates a window. Five healthcare services companies, or eight industrial distribution businesses, all with similar operational patterns, and you can systematically improve efficiency by 1-3% across all of them using lightweight automation and common playbooks. 

The math shifts dramatically when you aggregate AI in private equity. Build the automation playbook once: the workflows, the integrations, the process documentation. Deploy lightweight versions to each portfolio company. Your investment per company drops to $50,000 – $100,000. Your return hurdle becomes 1-2% EBITDA improvement per company. 

That’s achievable. Standardized AR workflows, automated reporting dashboards, and customer intake automation can realistically deliver 1-3% efficiency gains. 

Run it across eight companies: invest $500,000 -$1M over two to three years, generate $2-4M in enterprise value across the portfolio. That’s a 2-4x return on your operational excellence investment. 

The alpha here isn’t waiting for a packaged solution. It’s in doing the unglamorous mop bucket work now: building the playbooks, deploying the automations, learning what actually moves the needle, while others wait for the market to mature.

The Software House Trap 

Whether you’re pursuing incremental efficiency or sector moonshots, the temptation is to think: “We should build a team. We could create proprietary tools. Maybe even license them after exit.” 

Resist this. You’re a three-to five-year investor, not a ten-year product company. Software requires ongoing maintenance. Your portfolio companies will resist “fund-imposed tech” the moment you exit. And you can’t recruit top engineers for fund-level operational work; they want to build products, not internal tools for a rotating set of companies. 

Your team should be two to three people maximum: one automation specialist who knows APIs and light scripting, one process consultant who understands the business problems and one data person who ensures you’re feeding clean inputs to the automation. That’s not an engineering team. That’s orchestration. 

For moonshots, you partner or acqui-hire. You don’t build from scratch. 

The takeaway here is straightforward: AI value creation behaves much more like operational excellence than technology innovation. 

Firms that treat AI as a portfolio capability – built once, deployed many times- see fundamentally different economics than those running isolated experiments. 

The remaining question is where to focus. Not every function is equally important, nor does every improvement affect valuation.  

In our next post, we’ll look at where AI consistently drives EBITDA in PE-backed businesses and why sector concentration matters more than the technology itself.